SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Tesla is trending amid a noticeable surge, with community members debating whether it's primed for further gains or an overextended meme stock due for a correction. The stock's movement follows news of Nevada approving Tesla's robotaxi testing, alongside commentary around Elon Musk's leadership and the company's valuation.

Super Micro Computer, Inc. engages in the distribution and manufacture of information technology solutions and other computer products. Its products include twin solutions, MP servers, GPU and coprocessor, MicroCloud, AMD solutions, power supplies, SuperServer, storage, motherboards, chassis, super workstations, accessories, SuperRack and server management products. The company was founded by Charles Liang, Yih-Shyan Liaw, Sara Liu, and Chiu-Chu Liu Liang in September 1993 and is headquartered in San Jose, CA.

Super Micro Computer Inc

SMCI is trending due to the commencement of volume shipments of its NVIDIA Blackwell Ultra systems, a development sparking bullish sentiment among investors. The community is actively discussing the potential for earnings revisions and a stock re-rating, while also weighing the company's historical compliance issues. Some believe the stock is undervalued with substantial upside, while others remain cautious.

IonQ, Inc. develops and manufactures quantum computers. The firm specializes in quantum computing and quantum information processing. The company was founded by Christopher Monroe and Jung Sang Kim in 2015 and is headquartered in College Park, MD.

IonQ Inc

IONQ is experiencing a surge, with the community actively discussing a potential breakout and analyst day catalysts. Some are attributing the rise to early volume and strength, while others point to the acquisition of Oxford Ionics and potential short squeeze. The community is speculating on price targets and whether to sell or hold.

Adobe, Inc. is a global technology company, which engages in the provision of digital marketing and media solutions. It operates through the following segments: Digital Media, Digital Experience, and Publishing and Advertising. The Digital Media segment offers products and services that enable individuals, teams, businesses, and enterprises to create, publish, and promote content anywhere and accelerate productivity by transforming view, share, engage with and collaborate on documents and creative content. The Digital Experience segment focuses on integrated platform and set of products, services, and solutions that enable businesses to create, manage, execute, measure, monetize, and optimize customer experiences that span from analytics to commerce. The Publishing and Advertising segment includes legacy products and services that address diverse market opportunities, including eLearning solutions, technical document publishing, web conferencing, document and forms platform, web app development, high-end printing, and Adobe Advertising offerings. The company was founded by Charles M. Geschke and John E. Warnock in December 1982 and is headquartered in San Jose, CA.

Adobe Inc

Adobe's stock is trending amid discussions about its earnings and future growth potential, with some traders citing analyst upgrades and AI integration as reasons for optimism. However, many community members express concerns about market manipulation and the stock's historical performance post-earnings, leading to mixed sentiment and active debate on potential price movements. Some users speculate about the impact of AI competition and the possibility of a turnaround, while others express frustration with the stock's perceived underperformance despite positive results.

BigBear.ai Holdings, Inc. engages in data-driven decision dominance and advanced analytics that provide its customers with a competitive advantage in a world driven by data that is growing in terms of volume, variety, and velocity. The firm operationalizes artificial intelligence and machine learning at scale through its end-to-end data analytics platform. It deploys its observe, orient and dominate products to customers throughout the defense, intelligence, and commercial markets. The company was founded in 2020 and is headquartered in McLean, VA.

BigBear.ai Holdings Inc

BigBear.ai (BBAI) is trending as social media buzzes with anticipation of a potential short squeeze and speculation around new contracts, especially following news of their technology accelerating passenger processing at Nashville International Airport. The community is closely watching for a breakout, drawing comparisons to Palantir and emphasizing the company's role in AI-driven security solutions. Discussions also highlight the stock's chart setup and potential for significant gains, creating a mix of excitement and high expectations.

GlucoTrack, Inc. designs, develops, and commercializes non-invasive glucose monitoring devices for use by persons suffering from diabetes. The company offers the GlucoTrack model DF-F glucose monitoring device, which utilizes a patented combination of ultrasound, electromagnetic and thermal technologies to obtain glucose measurements in less than one minute via a small sensor that is clipped onto one's earlobe and connected to a small, handheld control and display unit, all without drawing blood or interstitial fluid. It was designed to help people with diabetes and pre-diabetics obtain glucose level readings without the pain. The company was founded by Avner Gal and David Malka in September 2001 and is headquartered in Rutherford, NJ.

GlucoTrack Inc

GCTK is trending due to a recent $20 million stock purchase agreement, sparking significant community discussion around a potential short squeeze and future price targets. The company's small float and high short interest are fueling speculation, while upcoming conference participation is anticipated to bring further news. Community members are actively debating the stock's potential for substantial gains versus the risk of a pullback.

Galectin Therapeutics, Inc. is a biotechnology company, which engages in drug research and development to create new therapies for fibrotic disease, severe skin disease, and cancer. Its programs target the development of carbohydrate molecules which offers alternative options to larger market segments. The company was founded by James C. Czirr and Anatole A. Klyosov on July 10, 2000 and is headquartered in Norcross, GA.

Galectin Therapeutics Inc

GALT is trending due to community excitement around its potential in treating liver diseases, particularly MASH cirrhosis, and speculation about a possible buyout. Bullish investors express confidence, citing insider ownership and promising data, while also noting a high short interest that could lead to a significant short squeeze. Concerns remain about potential short-term volatility and the need for continued positive developments.

Opendoor Technologies, Inc. engages in the operation of buying, selling, and trading of residential properties online. The company was founded by Eric Wu on December 30, 2013, and is headquartered in Tempe, AZ.

Opendoor Technologies Inc

The stock is trending amid discussions of a potential short squeeze, driven by a new CEO and board changes. Community members are actively debating dip-buying strategies and anticipating further upward momentum, while also watching for potential pullbacks and profit-taking.

The TROLL token on the Solana network is a meme coin inspired by internet trolling culture, designed for entertainment and community engagement with no intrinsic value. Built on Solana’s blockchain, it leverages the network’s fast transactions and low fees to appeal to meme enthusiasts. Launched on decentralized exchanges, TROLL aims to foster a fun, community-driven ecosystem through social media, influencer partnerships, and viral marketing, embodying the playful spirit of online trolling.

Troll

$TROLL.X is experiencing a surge in interest, fueled by bullish sentiment and anticipation of a potential breakout, with community members highlighting strong chart setups and accumulation patterns. The crypto community is drawing attention to the meme token's momentum and suggesting a significant upward move is imminent, possibly echoing past memecoin successes. Some users have noted that the project acquired rights to the Trollface meme.

Warner Bros. Discovery, Inc. is a premier global media and entertainment company, which engages in the provision of a differentiated portfolio of content, brands, and franchises across television, film, streaming, and gaming. It operates through the following segments: Studios, Networks, Direct-to-Consumer (DTC), and Corporate. The Studios segment includes producing and releasing feature films for initial exhibition in theaters, producing and initial licensing television programs to networks services as well as third parties, distributing films and television programs to various third party, internal television, and streaming services, distribution through the home entertainment market related consumer products, and themed experience licensing and interactive gaming. The Networks segment focuses on domestic and international television networks. The DTC segment is involved in premium pay-television and streaming services. The company was founded on June 17, 1985 and is headquartered in New York, NY.

Warner Bros. Discovery Inc - Ordinary Shares - Class A

Warner Bros Discovery Inc

Warner Bros. Discovery is trending amid speculation of a potential buyout offer from Paramount Skydance, reportedly backed by the Ellison family, sparking significant community discussion around the deal's valuation and potential bidding wars.  Many are closely watching for confirmation and details around the offer price, while considering the implications for the broader streaming landscape and WBD's future strategy. Community members are debating the likelihood of the deal and how a merger could reshape the entertainment industry.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

TVTX Stock Soars as FDA Waives Advisory Committee for Filspari sNDA

Travere Therapeutics stock jumps after the FDA drops advisory meeting for Filspari's FSGS filing, with approval decision due in January 2026.

RARE Reports Positive Long-Term Data From Metabolic Disorder Study

Ultragenyx posts 96-week data showing DTX401 sharply cuts cornstarch needs and improves life quality in GSDIa patients.

IMVT Stock Up 11% on Upbeat Batoclimab Hyperthyroidism Study Results

Immunovant stock jumps 11% after new batoclimab study results showed durable thyroid hormone control in Graves' disease patients.

Cytokinetics Gains on Positive Late-Stage Cardiomyopathy Study Results 

CYTK shares soar 40% after phase III MAPLE-HCM results showed that aficamten outperformed metoprolol in obstructive HCM.

Editas Nominates EDIT-401 as Lead In Vivo Therapy for High Cholesterol

EDIT nominates EDIT-401, a one-time in vivo gene editing therapy, as its lead pipeline candidate to cut the risk of elevated cholesterol.

Recent Price Trend in Kiniksa Pharmaceuticals International, plc (KNSA) is Your Friend, Here's Why

Kiniksa Pharmaceuticals International, plc (KNSA) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through our shorter-term trading strategy-based screen.

Court Ruling & Tariff Uncertainty: Time to Bet on POST, TME & KNSA?

Court ruling on tariffs fuels market jitters, making low-beta picks like Post, Tencent Music and Kiniksa attractive options.

ALNY/RHHBY's Zilebesiran to Enter Phase III After Third Phase II Win

Alnylam and Roche report positive phase II KARDIA-3 results for zilebesiran in high-risk hypertension patients, fueling momentum for a phase III study.

OTLK Stock Crashes 54% as FDA Issues Second CRL for Eye Disease Drug

Outlook Therapeutics stock plunges 54% after the FDA rejects ONS-5010 BLA again, citing lack of efficacy data in confirmatory study.

INO Stock Soars as FDA Backs Rolling BLA for Rare Lung Disease Drug

Inovio stock surges 21% after the FDA gives green light to begin a rolling BLA for its RRP drug INO-3107, with plans to seek priority review.

Kiniksa Pharmaceuticals International Plc is a commercial-stage biopharmaceutical company. It engages in discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical need. The company was founded on April 9, 2024 and is headquartered in London, United Kingdom.

Current Price	$37.21
Prev Close	$37.01
Open	$36.96
Dividend Yield	0.00%
50-Day Moving Average	$31.56
Beta	0.72
Avg. Volume	543,917.95
PE Ratio	900.49

52-Week High	$37.25
52-Week Low	$17.82
Market Capitalization	$2.74B
EPS (Annual)	-$0.6047
Price to Book	5.54
Revenue Per Employee	$1.34M
Enterprise Value/EBITDA	N/A

KNSA
Kiniksa Pharmaceuticals Ltd - Ordinary Shares - Class A

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest KNSA News

KNSA Kiniksa Pharmaceuticals Ltd - Ordinary Shares - Class A